Product Code: GVR-4-68038-850-3
Pupillometer Market Growth & Trends
The global pupillometer market size is expected to reach USD 673.9 million by 2030, registering a CAGR of 6.85% according to a new report by Grand View Research, Inc. Adoption of pupillometry is on the rise as an assessment examination for diagnosing various health conditions. This growth in adoption is leading to the development of advanced pupillometer devices for faster and more accurate diagnosis.
Research has shown that a large number of neurological disorders have a direct impact on pupil size and hence can be diagnosed through pupillometry exams. Moreover, understanding the changes occurring in pupil characteristics helps clinicians in performing various neurological surgeries. Pupillometers are widely being used in critical care units, as pupillometry is becoming a protocol for primary diagnosis.
The pupillary light reflex (PLR) acts as an indication and clinical parameter for diagnosing various diseases. Since the demand for pupillometers is increasing, many nursing, educational, and research centers are providing training regarding pupillometry. These pieces of training help in increasing the number of skilled professionals. Pupillometry is becoming a prerequisite in many settings; therefore, companies are developing integrated devices with pupillometry to provide settings such as hospitals with all-in-one devices.
Market players are participating in trade shows and exhibitions, and are conducting conferences to increase awareness regarding pupillometry and the reach of their pupillometers. Additionally, these market players are developing handheld devices to resolve the issue of mobility and to increase the accessibility of the device in various settings. Moreover, companies have come up with technologically advanced software which can be installed on mobile devices to complete the process of pupillometry through mobile.
Video pupillometer is preferred more, as it helps in capturing the entire procedure of pupil dilation in a more detailed manner. The video pupillometer helps in capturing the pupil characteristics and its reactivity over time, which in turn is expected to enhance the diagnosis process. On the other hand, the development of digital pupillometers is gaining momentum. The digital pupillometer offers advantages such as mobility, accuracy, instant results, and efficiency. These devices help in conducting rapid assessments, which, in turn, is expected to boost the overall market growth.
Pupillometer Market Report Highlights
- Table-top pupillometers held the dominant share in 2022, as market players are focusing on the development of integrated pupillometer devices along with keratometers, pachymeters, and wavefront aberrometer
- The hand-held pupillometer is expected to expand at the fastest rate during the forecast period owing to its easy accessibility and accuracy
- The digital pupillometer segment is expected to advance at the highest CAGR as these devices provide instant and accurate results
- Hospitals held the largest share in 2021 due to the growing installation of pupillometers in this setting
- The eye clinics segment is expected to grow at the fastest rate during the forecast period due to the growing adoption of pupillometry in various ophthalmic clinics
- The ophthalmology segment held the largest share in 2022 owing to the growing usage of pupillometry in understanding damage to the inner and outer retina
- North America held the largest share in 2022 owing to the increasing prevalence of vision-related problems in this region, along with the growing awareness and adoption of pupillometry
- The Asia Pacific is expected to experience the fastest growth rate during the forecast period, mainly due to the increasing availability of pupillometers through online platforms and suppliers
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Mobility
- 1.1.2. Type
- 1.1.3. End-Use
- 1.1.4. Application
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Obje
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Pupillometer Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing number of neurological disorders
- 3.4.1.2. Increasing number of vision-related issues
- 3.4.1.3. Growing number of product launches
- 3.4.2. Market restraint analysis
- 3.4.2.1. Challenges associated with usage of pupillometer
- 3.4.3. Industry challenges
- 3.5. Pupillometer Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Pupillometer: Mobility Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Table-top
- 4.1.2. Hand-held
- 4.2. Mobility Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Pupillometer Market by Mobility Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 4.5.1. Table-top
- 4.5.1.1. Market estimates and forecast 2017 - 2030 (USD Million)
- 4.5.2. Hand-held
- 4.5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 5. Pupillometer: Type Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Video
- 5.1.2. Digital
- 5.2. Type Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Pupillometer Market by Type Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 5.5.1. Video
- 5.5.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
- 5.5.2. Digital
- 5.5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 6. Pupillometer: End-Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Eye Clinics
- 6.1.3. Others
- 6.2. End-Use Market Share, 2022 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Pupillometer Market by End-Use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
- 6.5.2. Eye clinics
- 6.5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
- 6.5.3. Others
- 6.5.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 7. Application Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.1.1. Ophthalmology
- 7.1.2. Neurology
- 7.1.3. Oncology
- 7.1.4. Others
- 7.2. Application Market Share, 2022 & 2030
- 7.3. Segment Dashboard
- 7.4. Global Pupillometer Market by Application Outlook
- 7.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 7.5.1. Ophthalmology
- 7.5.1.1. Market estimates and forecast, 2017 - 2030 (USD Million)
- 7.5.2. Neurology
- 7.5.2.1. Market estimates and forecast, 2017 - 2030 (USD Million)
- 7.5.3. Oncology
- 7.5.3.1. Market estimates and forecast, 2017 - 2030 (USD Million)
- 7.5.4. Others
- 7.5.4.1. Market estimates and forecast, 2017 - 2030 (USD Million)
Chapter 8. Pupillometer Market: Regional Estimates & Trend Analysis
- 8.1. Regional market share analysis, 2022 & 2030
- 8.2. Regional Market Dashboard
- 8.3. Global Regional Market Snapshot
- 8.4. Regional Market Share and Leading Players, 2022
- 8.4.1. North America
- 8.4.2. Europe
- 8.4.3. Asia Pacific
- 8.4.4. Latin America
- 8.4.5. Middle East and Africa
- 8.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 8.5.1. North America
- 8.5.2. Europe
- 8.5.3. Asia Pacific
- 8.5.4. Latin America
- 8.5.5. Middle East and Africa
- 8.6. Market Size, & Forecasts and Trend Analysis, 2017 to 2030
- 8.7. North America
- 8.7.1. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.7.2. U.S.
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Regulatory Framework & Reimbursement Structure
- 8.7.2.3. Competitive Scenario
- 8.7.2.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.7.3. Canada
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Regulatory Framework & Reimbursement Structure
- 8.7.3.3. Competitive Scenario
- 8.7.3.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8. Europe
- 8.8.1. UK
- 8.8.1.1. Key Country Dynamics
- 8.8.1.2. Regulatory Framework & Reimbursement Structure
- 8.8.1.3. Competitive Scenario
- 8.8.1.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.2. Germany
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Regulatory Framework & Reimbursement Structure
- 8.8.2.3. Competitive Scenario
- 8.8.2.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.3. France
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Regulatory Framework & Reimbursement Structure
- 8.8.3.3. Competitive Scenario
- 8.8.3.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.4. Italy
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Regulatory Framework & Reimbursement Structure
- 8.8.4.3. Competitive Scenario
- 8.8.4.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.5. Spain
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Regulatory Framework & Reimbursement Structure
- 8.8.5.3. Competitive Scenario
- 8.8.5.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.6. Denmark
- 8.8.6.1. Key Country Dynamics
- 8.8.6.2. Regulatory Framework & Reimbursement Structure
- 8.8.6.3. Competitive Scenario
- 8.8.6.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.7. Sweden
- 8.8.7.1. Key Country Dynamics
- 8.8.7.2. Regulatory Framework & Reimbursement Structure
- 8.8.7.3. Competitive Scenario
- 8.8.7.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.8. Switzerland
- 8.8.8.1. Key Country Dynamics
- 8.8.8.2. Regulatory Framework & Reimbursement Structure
- 8.8.8.3. Competitive Scenario
- 8.8.8.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.9. Norway
- 8.8.9.1. Key Country Dynamics
- 8.8.9.2. Regulatory Framework & Reimbursement Structure
- 8.8.9.3. Competitive Scenario
- 8.8.9.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.8.10. Poland
- 8.8.10.1. Key Country Dynamics
- 8.8.10.2. Regulatory Framework & Reimbursement Structure
- 8.8.10.3. Competitive Scenario
- 8.8.10.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9. Asia Pacific
- 8.9.1. Japan
- 8.9.1.1. Key Country Dynamics
- 8.9.1.2. Regulatory Framework & Reimbursement Structure
- 8.9.1.3. Competitive Scenario
- 8.9.1.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.2. China
- 8.9.2.1. Key Country Dynamics
- 8.9.2.2. Regulatory Framework & Reimbursement Structure
- 8.9.2.3. Competitive Scenario
- 8.9.2.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.3. India
- 8.9.3.1. Key Country Dynamics
- 8.9.3.2. Regulatory Framework & Reimbursement Structure
- 8.9.3.3. Competitive Scenario
- 8.9.3.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.4. Thailand
- 8.9.4.1. Key Country Dynamics
- 8.9.4.2. Regulatory Framework & Reimbursement Structure
- 8.9.4.3. Competitive Scenario
- 8.9.4.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.5. South Korea
- 8.9.5.1. Key Country Dynamics
- 8.9.5.2. Regulatory Framework & Reimbursement Structure
- 8.9.5.3. Competitive Scenario
- 8.9.5.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.6. Indonesia
- 8.9.6.1. Key Country Dynamics
- 8.9.6.2. Regulatory Framework & Reimbursement Structure
- 8.9.6.3. Competitive Scenario
- 8.9.6.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.7. Australia
- 8.9.7.1. Key Country Dynamics
- 8.9.7.2. Regulatory Framework & Reimbursement Structure
- 8.9.7.3. Competitive Scenario
- 8.9.7.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.8. Hong Kong
- 8.9.8.1. Key Country Dynamics
- 8.9.8.2. Regulatory Framework & Reimbursement Structure
- 8.9.8.3. Competitive Scenario
- 8.9.8.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.9. Philippines
- 8.9.9.1. Key Country Dynamics
- 8.9.9.2. Regulatory Framework & Reimbursement Structure
- 8.9.9.3. Competitive Scenario
- 8.9.9.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.9.10. Malaysia
- 8.9.10.1. Key Country Dynamics
- 8.9.10.2. Regulatory Framework & Reimbursement Structure
- 8.9.10.3. Competitive Scenario
- 8.9.10.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.10. Latin America
- 8.10.1. Brazil
- 8.10.1.1. Key Country Dynamics
- 8.10.1.2. Regulatory Framework & Reimbursement Structure
- 8.10.1.3. Competitive Scenario
- 8.10.1.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.10.2. Mexico
- 8.10.2.1. Key Country Dynamics
- 8.10.2.2. Regulatory Framework & Reimbursement Structure
- 8.10.2.3. Competitive Scenario
- 8.10.2.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.10.3. Argentina
- 8.10.3.1. Key Country Dynamics
- 8.10.3.2. Regulatory Framework & Reimbursement Structure
- 8.10.3.3. Competitive Scenario
- 8.10.3.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.10.4. Colombia
- 8.10.4.1. Key Country Dynamics
- 8.10.4.2. Regulatory Framework & Reimbursement Structure
- 8.10.4.3. Competitive Scenario
- 8.10.4.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.10.5. Chile
- 8.10.5.1. Key Country Dynamics
- 8.10.5.2. Regulatory Framework & Reimbursement Structure
- 8.10.5.3. Competitive Scenario
- 8.10.5.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.11. MEA
- 8.11.1. South Africa
- 8.11.1.1. Key Country Dynamics
- 8.11.1.2. Regulatory Framework & Reimbursement Structure
- 8.11.1.3. Competitive Scenario
- 8.11.1.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.11.2. Saudi Arabia
- 8.11.2.1. Key Country Dynamics
- 8.11.2.2. Regulatory Framework & Reimbursement Structure
- 8.11.2.3. Competitive Scenario
- 8.11.2.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.11.3. UAE
- 8.11.3.1. Key Country Dynamics
- 8.11.3.2. Regulatory Framework & Reimbursement Structure
- 8.11.3.3. Competitive Scenario
- 8.11.3.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.11.4. Kuwait
- 8.11.4.1. Key Country Dynamics
- 8.11.4.2. Regulatory Framework & Reimbursement Structure
- 8.11.4.3. Competitive Scenario
- 8.11.4.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
- 8.11.5. Qatar
- 8.11.5.1. Key Country Dynamics
- 8.11.5.2. Regulatory Framework & Reimbursement Structure
- 8.11.5.3. Competitive Scenario
- 8.11.5.4. Market estimates and forecast, 2017 - 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis, By Key Market Participants
- 9.2. Company/Competition Categorization
- 9.2.1. Innovators
- 9.2.2. Market Leaders
- 9.2.3. Emerging Players
- 9.3. Vendor Landscape
- 9.3.1. List of key distributors and channel partners
- 9.3.2. Key customers
- 9.3.3. Key company market share analysis, 2021
- 9.3.4. NeurOptics, Inc.
- 9.3.4.1. Company overview
- 9.3.4.2. Financial performance
- 9.3.4.3. Product benchmarking
- 9.3.4.4. Strategic initiatives
- 9.3.5. Adaptica
- 9.3.5.1. Company overview
- 9.3.5.2. Financial performance
- 9.3.5.3. Product benchmarking
- 9.3.5.4. Strategic initiatives
- 9.3.6. Essilor Instruments USA
- 9.3.6.1. Company overview
- 9.3.6.2. Financial performance
- 9.3.6.3. Product benchmarking
- 9.3.6.4. Strategic initiatives
- 9.3.7. HAAG-STREIT GROUP
- 9.3.7.1. Company overview
- 9.3.7.2. Financial performance
- 9.3.7.3. Product benchmarking
- 9.3.7.4. Strategic initiatives
- 9.3.8. Johnson & Johnson Vision
- 9.3.8.1. Company overview
- 9.3.8.2. Financial performance
- 9.3.8.3. Product benchmarking
- 9.3.8.4. Strategic initiatives
- 9.3.9. Luneau Technology Group
- 9.3.9.1. Company overview
- 9.3.9.2. Financial performance
- 9.3.9.3. Product benchmarking
- 9.3.9.4. Strategic initiatives
- 9.3.10. NIDEK CO., LTD.
- 9.3.10.1. Company overview
- 9.3.10.2. Financial performance
- 9.3.10.3. Product benchmarking
- 9.3.10.4. Strategic initiatives
- 9.3.11. Reichert Technologies
- 9.3.11.1. Company overview
- 9.3.11.2. Financial performance
- 9.3.11.3. Product benchmarking
- 9.3.11.4. Strategic initiatives
- 9.3.12. SCHWIND eye-tech-solutions
- 9.3.12.1. Company overview
- 9.3.12.2. Financial performance
- 9.3.12.3. Product benchmarking
- 9.3.12.4. Strategic initiatives
- 9.3.13. US Ophthalmic
- 9.3.13.1. Company overview
- 9.3.13.2. Financial performance
- 9.3.13.3. Product benchmarking
- 9.3.13.4. Strategic initiatives
- 9.3.14. Konan Medical
- 9.3.14.1. Company overview
- 9.3.14.2. Financial performance
- 9.3.14.3. Product benchmarking
- 9.3.14.4. Strategic initiatives
- 9.3.15. brightlamp, Inc.
- 9.3.15.1. Company overview
- 9.3.15.2. Financial performance
- 9.3.15.3. Product benchmarking
- 9.3.15.4. Strategic initiatives